Publicação
Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol
| dc.contributor.author | Caldeira, Daniel | |
| dc.date.accessioned | 2018-07-23T13:35:41Z | |
| dc.date.available | 2018-07-23T13:35:41Z | |
| dc.date.issued | 2018 | |
| dc.description | © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | BMJ Evidence-Based Medicine Published Online First: 17 July 2018 | pt_PT |
| dc.identifier.doi | 10.1136/bmjebm-2018-110976 | pt_PT |
| dc.identifier.issn | 2515-446X | |
| dc.identifier.uri | http://hdl.handle.net/10451/34328 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | BMJ Publishing Group | pt_PT |
| dc.relation.publisherversion | https://ebm.bmj.com/ | pt_PT |
| dc.title | Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | BMJ Evidence Based Medicine | pt_PT |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |